Form 4 for BEAM Beam Therapeutics Inc.
Accepted 2025-01-02 00:00:00 ET · period of report 2024-12-31 · accession 0000950170-25-000624 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-02 | 2024-12-31 | BEAM | Emany Sravan Kumar | CFO | A - Grant | $0.00 | +80.0K | 80.0K | New | $0 |
| D | 2025-01-02 | 2024-12-31 | BEAM | Emany Sravan Kumar | CFO | A - Grant | $0.00 | +160.0K | 160.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-31 | A | A | 80,000 | $0.00 | 80,000 | D | — | — | (F1) Represents restricted stock units ("RSUs") granted to the Reporting Person under the Beam Therapeutics Inc. ("BEAM") 2019 Equity Incentive Plan (the "Plan"). Each RSU represents the contingent right to receive one share of BEAM's common stock. The RSU vests in four substantially equal installments on each of the first four anniversaries of December 31, 2024, subject to the Reporting Person's continued service with BEAM through each vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-12-31 | A | A | 160,000 | $0.00 | 160,000 | D | $24.80 · — to 2034-12-31 | 160,000 Common Stock | (F2) This stock option vests as to 25% on the first anniversary of the vesting commencement date, December 31, 2024, and at a rate of 2.78% each month thereafter until the option is fully vested. |